Company: DMAAR
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001213900-25-026240
Chunk: 742

Company: Drugs Made In America Acquisition Corp.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 9
Chunk 742
---
 Officer’s compensation, evaluating our Chief Executive Officer’s
performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer
based on such evaluation;

●reviewing and making recommendations to our board
of directors with respect to the compensation, and any incentive-compensation and equity-based plans that are subject to board approval
of all of our other officers;

●reviewing our executive compensation policies
and plans;

●implementing and administering our incentive
compensation equity-based remuneration plans;

●assisting management in complying with our proxy
statement and annual report disclosure requirements;

●approving all special perquisites, special cash
payments and other special compensation and benefit arrangements for our officers and employees;

●producing a report on executive compensation
to be included in our annual proxy statement; and

●reviewing, evaluating and recommending changes,
if appropriate, to the remuneration for directors.

20

The charter also provides that the compensation
committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, independent legal counsel or other adviser
and will be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging
or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee will consider
the independence of each such adviser, including the factors required by Nasdaq and the SEC.

We have not formally established any specific,
minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating
nominees for director, the board of directors considers educational background, diversity of professional experience, knowledge of our
business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our shareholders.
Prior to our initial business combination, holders of our public shares will not have the right to recommend director candidates for nomination
to our board of directors.

Compensation Committee Interlocks and Insider Participation

None of our officers currently serves, and in
the past year has not served, (i) as a member of the compensation committee or board of directors of another entity, one of whose executive
officers served on our compensation committee, or (ii) as a member of the compensation committee of another entity, one of whose executive
officers served on our board of directors.

Director Nominations

We do not have a standing nominating committee,
though we intend to form a corporate governance and nomin